title: Averting hepatocellular carcinoma in chronic hepatitis B with antiviral therapy: tipping the balance or not yet?
authors.affiliation: Toronto Center for Liver Diseases, Toronto Western and General Hospital, University Health Network, University of Toronto, Toronto, Canada; Department of Gastroenterology and Hepatology, Erasmus MC University Hospital Rotterdam, Rotterdam, the Netherlands. Electronic address: harry.janssen@uhn.ca.
authors.forename: Harry L A
authors.initials: HL
authors.lastname: Janssen
authors.affiliation: Toronto Center for Liver Diseases, Toronto Western and General Hospital, University Health Network, University of Toronto, Toronto, Canada.
authors.forename: Ambreen
authors.initials: A
authors.lastname: Arif
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000453:epidemiology*; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology*; D008297:Male; D009705:Nucleosides / Q000627:therapeutic use*; D009711:Nucleotides / Q000627:therapeutic use*
chemical_list: D009705:Nucleosides; D009711:Nucleotides